241 related articles for article (PubMed ID: 33760416)
21. [Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?].
Charlot A; Boumiza R; Roux M; Zoll J
Biol Aujourdhui; 2021; 215(1-2):63-72. PubMed ID: 34397376
[TBL] [Abstract][Full Text] [Related]
22. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
23. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
24. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
26. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
Front Immunol; 2020; 11():1714. PubMed ID: 32793244
[TBL] [Abstract][Full Text] [Related]
27. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood.
Muscogiuri G; Bettini S; Boschetti M; Barrea L; Savastano S; Colao A;
Int J Obes (Lond); 2022 Jul; 46(7):1254-1261. PubMed ID: 35393519
[TBL] [Abstract][Full Text] [Related]
28. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
[TBL] [Abstract][Full Text] [Related]
29. Obesity and covid-19: a reflection on the relationship between pandemics.
Bolsoni-Lopes A; Furieri L; Alonso-Vale MIC
Rev Gaucha Enferm; 2021; 42(spe):e20200216. PubMed ID: 33787725
[TBL] [Abstract][Full Text] [Related]
30. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
31. [Severe COVID-19, a new complication to be added to numerous comorbidities associated to obesity].
De Flines J; Scheen AJ
Rev Med Liege; 2020 Sup; 75(S1):146-152. PubMed ID: 33211438
[TBL] [Abstract][Full Text] [Related]
32. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
33. Cytokine storm and the prospects for immunotherapy with COVID-19.
Calabrese LH
Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
[TBL] [Abstract][Full Text] [Related]
34. Obesity as a risk factor for COVID-19: an overview.
Alberca RW; Oliveira LM; Branco ACCC; Pereira NZ; Sato MN
Crit Rev Food Sci Nutr; 2021; 61(13):2262-2276. PubMed ID: 32539446
[TBL] [Abstract][Full Text] [Related]
35. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
[TBL] [Abstract][Full Text] [Related]
36. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M
J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354
[TBL] [Abstract][Full Text] [Related]
37. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.
Cai SH; Liao W; Chen SW; Liu LL; Liu SY; Zheng ZD
Infect Dis Poverty; 2020 Jun; 9(1):80. PubMed ID: 32600411
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
[TBL] [Abstract][Full Text] [Related]
39. Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects.
Fitzgerald PJ
Med Hypotheses; 2020 Nov; 144():109985. PubMed ID: 32554324
[No Abstract] [Full Text] [Related]
40. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
